15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $96M | -$5M | 64.6% | -17.3% | $11M | $5M | $33M |
| 2024 | $75M | -$20M | 67.1% | -6.0% | $5M | $16M | $92M |
| 2023 | $68M | -$68M | 60.7% | -25.3% | -$19M | $24M | $28M |
| 2022 | $76M | -$140M | 0.0% | -7.8% | -$19M | $26M | $19M |
| 2021 | $119M | -$9M | 0.0% | -29.5% | -$13M | $7M | $70M |
| 2020 | $48M | $2M | 0.0% | -13.0% | $5M | $1M | $90M |
| 2019 | $27M | -$2M | 0.0% | -0.8% | $538000 | $13000 | $6M |
| 2018 | $20M | -$25M | 68.5% | 18.5% | $2M | — | $31M |
| 2017 | $11M | -$3M | 61.2% | -9.6% | $461000 | — | $7M |
| 2016 | — | -$7M | — | — | -$4M | $4M | $1M |
| 2015 | — | -$4M | — | — | -$5M | — | $2M |
| 2014 | — | -$3M | — | — | -$4M | — | $3M |
| 2013 | — | -$1M | — | — | -$90663 | — | $156273 |
| 2012 | — | -$2M | — | — | -$296786 | — | $196478 |
| 2011 | — | -$2M | — | — | -$1M | — | $16864 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $28M | $1M | 63.6% | 0.1% | -$658000 | $2M | $23M |
| Dec '25 | $19M | $11M | 0.0% | 7.2% | — | $5M | $33M |
| Sep '25 | $28M | $621000 | 0.0% | -0.3% | — | $7M | $29M |
| Jun '25 | $25M | -$16M | 0.0% | -65.5% | — | $10M | $32M |
| Mar '25 | $22M | -$448000 | 67.1% | -2.3% | $2M | $13M | $67M |
| Dec '24 | $15M | $12M | 0.0% | 3.6% | — | $16M | $92M |
| Sep '24 | $21M | -$2M | 0.0% | -2.0% | — | $20M | $24M |
| Jun '24 | $20M | -$21M | 0.0% | -6.6% | — | $21M | $22M |
| Mar '24 | $18M | -$10M | 0.0% | -17.9% | — | $24M | $30M |
| Dec '23 | -$6M | -$15M | 0.0% | -184.0% | $1M | $24M | $28M |
| Sep '23 | $24M | -$29M | 0.0% | -65.6% | -$6M | $26M | $19M |
| Jun '23 | $29M | -$10M | 0.0% | -36.4% | -$8M | $26M | $21M |
| Mar '23 | $38M | -$14M | 0.0% | -36.1% | -$6M | $25M | $19M |
| Dec '22 | $44M | -$49M | 0.0% | -111.3% | $3M | $26M | $19M |
| Sep '22 | $41M | -$10M | 0.0% | -28.8% | -$950000 | $26M | $27M |
| Jun '22 | $41M | -$73M | 0.0% | -188.9% | -$12M | $8M | $24M |
| Mar '22 | $36M | -$7M | 0.0% | -22.0% | -$9M | $7M | $59M |
| Dec '21 | $37M | -$16M | 0.0% | -49.5% | -$2M | $7M | $70M |
| Sep '21 | $34M | $79000 | 0.0% | -33.0% | -$329000 | $8M | $75M |
| Jun '21 | $31M | $8M | 0.0% | -14.6% | -$10M | $8M | $76M |
How the market has priced BLFS against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Biolife Solutions Inc's revenue has grown 14.9% per year. These are computed facts, not advice.
As of FY2025, Biolife Solutions Inc reported $5M of total debt against $33M of cash.
In FY2025, gross margin was 64.6%, operating margin -17.3%, and net margin -4.8%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.